683 Capital Management »

BTCS shares owned by 683 Capital Management

Quarter-by-quarter ownership of BTCS (BTCS) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in BTCS

Tip: Access up to 7 years of quarterly data

All positions including BTCS held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BTCS by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $428k 162k 2.64

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. Put Option (LLY)
Capital One Financial (COF)
Tesla Motors Put Option (TSLA)
NVIDIA Corporation Put Option (NVDA)
Wave Life Sciences SHS (WVE)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Alnylam Pharmaceuticals (ALNY)
Praxis Precision Medicines I Com New Put Option (PRAX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Gxo Logistics Incorporated Common Stock (GXO)
Hilton Grand Vacations (HGV)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding BTCS

State Street Corporation
Vanguard Group
Geode Capital Management
BlackRock
Jane Street
Susquehanna International
Mirae Asset Global Etfs Holdings
Renaissance Technologies
UBS Group
Vident Advisory
683 Capital Management
Northern Trust
Point72 Asset Management
Citadel Advisors
Commonwealth Equity Services

View all funds holding BTCS